Medical Research
(H90)
990 on File
MMV MEDICINES FOR MALARIA VENTURE NORTH AMERICA INC
Financial strength (30%)
67/100
Reliability (20%)
50/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$12K
Total Revenue
$440
Total Expenses
$56K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
4290.2%
Fundraising Efficiency
N/A
Operating Reserve
1522.83x
Liability-to-Asset
52.2%
Revenue Diversification
91.5%
Compared with Peers
FY 2025
Compared with 378 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
4290.2% | 75.9% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
1522.8 mo | 44.2 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
52.2% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
91.5% | 100.0% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
300.5% | 2.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
115.7% | -2.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
96.2% | 20.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $12K | $440 | $56K | 4290.2% | — |
| 2024 | $3K | $204 | $64K | 5929.4% | — |
| 2023 | $2K | $190 | $73K | 6844.7% | — |
| 2022 | $863 | $175 | $84K | 9766.9% | — |
| 2021 | $27K | $541 | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.